These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21907696)

  • 1. Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.
    Gratio V; Loriot C; Virca GD; Oikonomopoulou K; Walker F; Diamandis EP; Hollenberg MD; Darmoul D
    Am J Pathol; 2011 Nov; 179(5):2625-36. PubMed ID: 21907696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors.
    Chung H; Hamza M; Oikonomopoulou K; Gratio V; Saifeddine M; Virca GD; Diamandis EP; Hollenberg MD; Darmoul D
    Biol Chem; 2012 Apr; 393(5):413-20. PubMed ID: 22505523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.
    Gratio V; Beaufort N; Seiz L; Maier J; Virca GD; Debela M; Grebenchtchikov N; Magdolen V; Darmoul D
    Am J Pathol; 2010 Mar; 176(3):1452-61. PubMed ID: 20056842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14.
    Ramachandran R; Eissa A; Mihara K; Oikonomopoulou K; Saifeddine M; Renaux B; Diamandis E; Hollenberg MD
    Biol Chem; 2012 Apr; 393(5):421-7. PubMed ID: 22505524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
    Ramsay AJ; Dong Y; Hunt ML; Linn M; Samaratunga H; Clements JA; Hooper JD
    J Biol Chem; 2008 May; 283(18):12293-304. PubMed ID: 18308730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.
    Walker F; Nicole P; Jallane A; Soosaipillai A; Mosbach V; Oikonomopoulou K; Diamandis EP; Magdolen V; Darmoul D
    Biol Chem; 2014 Sep; 395(9):1075-86. PubMed ID: 25153388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.
    Darmoul D; Gratio V; Devaud H; Lehy T; Laburthe M
    Am J Pathol; 2003 May; 162(5):1503-13. PubMed ID: 12707033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).
    Ramachandran R; Mihara K; Chung H; Renaux B; Lau CS; Muruve DA; DeFea KA; Bouvier M; Hollenberg MD
    J Biol Chem; 2011 Jul; 286(28):24638-48. PubMed ID: 21576245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer.
    Kryza T; Bock N; Lovell S; Rockstroh A; Lehman ML; Lesner A; Panchadsaram J; Silva LM; Srinivasan S; Snell CE; Williams ED; Fazli L; Gleave M; Batra J; Nelson C; Tate EW; Harris J; Hooper JD; Clements JA
    Mol Oncol; 2020 Jan; 14(1):105-128. PubMed ID: 31630475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase.
    Gratio V; Walker F; Lehy T; Laburthe M; Darmoul D
    Int J Cancer; 2009 Apr; 124(7):1517-25. PubMed ID: 19058300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
    Devetzi M; Trangas T; Scorilas A; Xynopoulos D; Talieri M
    Thromb Haemost; 2013 Apr; 109(4):716-25. PubMed ID: 23224034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase-activated receptors, targets for kallikrein signaling.
    Oikonomopoulou K; Hansen KK; Saifeddine M; Tea I; Blaber M; Blaber SI; Scarisbrick I; Andrade-Gordon P; Cottrell GS; Bunnett NW; Diamandis EP; Hollenberg MD
    J Biol Chem; 2006 Oct; 281(43):32095-112. PubMed ID: 16885167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
    Bouzid H; Soualmia F; Oikonomopoulou K; Soosaipillai A; Walker F; Louati K; Lo Dico R; Pocard M; El Amri C; Ignatenko NA; Darmoul D
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases.
    Stefansson K; Brattsand M; Roosterman D; Kempkes C; Bocheva G; Steinhoff M; Egelrud T
    J Invest Dermatol; 2008 Jan; 128(1):18-25. PubMed ID: 17625593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.
    Abdallah RT; Keum JS; El-Shewy HM; Lee MH; Wang B; Gooz M; Luttrell DK; Luttrell LM; Jaffa AA
    J Biol Chem; 2010 Nov; 285(45):35206-15. PubMed ID: 20826789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell.
    Nishibori M; Mori S; Takahashi HK
    J Pharmacol Sci; 2005 Jan; 97(1):25-30. PubMed ID: 15655297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
    Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
    Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.